Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Design and Rationale of "A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing MIdazolam Versus MOrphine in Acute Pulmonary Edema": MIMO Trial

NCT02856698 is registered in ClinicalTrials.gov with Alberto Dominguez-Rodriguez as lead sponsor.

NCT NCT02856698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02856698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Design and Rationale of "A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing MIdazolam Versus MOrphine in Acute Pulmonary Edema": MIMO Trial
Lead sponsor
Alberto Dominguez-Rodriguez
Phase
Phase 4
Overall status
Terminated
Start date
April 8, 2017
Completion date
December 31, 2020
Enrollment
111 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute pulmonary edema